Table 3.
Variables | Composite outcome | Cardiovascular outcome | All-cause mortality | |||
---|---|---|---|---|---|---|
Adjusted HR (95% CI) § | P | Adjusted HR (95% CI) § | P | Adjusted HR (95% CI) § | P | |
VAI (tertile 2 vs. tertile 1) | 1.5 (1.07-2.08) | 0.04 | 1.72 (1.13-2.63) | 0.01 | - | 0.8 |
VAI (tertile 3 vs. tertile 1) | 1.62 (1.22-2.32) | 0.04 | 1.69 (1.11-2.6) | 0.02 | - | 0.4 |
WC (every 10 cm increase) | - | 0.4 | - | 0.3 | - | 0.1 |
WHtR (every 0.01 unit increase) | - | 0.1 | - | 0.2 | - | 0.2 |
Taking VAI as a continuous variable | ||||||
VAI (every 1 unit increase) | 1.4 (1.23-2.25) | 0.01 | 1.69 (1.3-2.2) | 0.01 | - | 0.4 |
WC (every 10 cm increase) | - | 0.4 | - | 0.3 | - | 0.1 |
WHtR (every 0.01 unit increase) | - | 0.1 | - | 0.2 | - | 0.2 |
Abbreviations: VAI visceral adiposity index, WC waist circumference, WHtR waist-to-height ratio, HR hazard ratio, CI confidence interval, P P value, DM diabetic mellitus, CV cardiovascular, HTN hypertension, HD hemodialysis, hs-CRP highly-sensitive C-reactive protein, GNRI geriatric nutritional risk index, iPTH intact parathyroid hormone, CaxP calcium phosphate product.
§Adjusted for gender, age, HD vintage, presence of DM, HTN and concurrent CV disease, hemoglobin, iPTH, hs-CRP, calcium phosphate product and GNRI levels.
-: indicated non-selected in the stepwise likelihood ratio model.